Stroke and other silent cerebrovascular disease is highly prevalent in the African-American community. We are interested in examining how frontal lobe changes, due to cardiovascular risk, affect executive function, gait, and urinary bladder control.
Our laboratory currently tests a cohort of African-American older adults who have been classified in terms of risk for cerebrovascular disease. Once excluded for stroke, heart attack, severe psychiatric and other conditions that could affect cognitive performance, participants will be tested with a battery of neuropsychological tests, measures of gait and balance, and questionnaires focused on urinary function, and social history.
For more information about this study, please contact:
Colleen Barber by email ( ), or by phone: (857) 364-2093,